Abstract
Forty-eight patients with serosa-invaded advanced gastric cancer were administered to pre-operative intra-peritoneal chemotherapy to prevent peritoneal recurrence. There were no severe adverse effects from the intra-peritoneal chemotherapy. Of these patients, 2 showed malignant ileus shortly after intra-peritoneal chemotherapy and gastrectomy, and needed laparotomy because of dilatation of duodenum stump and liver dysfunction. The intestines and mesothelium showed diffuse thickness and hardness. We report the clinicopathological features of these cases and therapeutic limitation of intra-peritoneal chemotherapy.
Publication types
-
Case Reports
-
English Abstract
MeSH terms
-
Adenocarcinoma, Scirrhous / complications
-
Adenocarcinoma, Scirrhous / drug therapy*
-
Adenocarcinoma, Scirrhous / pathology
-
Adenocarcinoma, Scirrhous / surgery
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects*
-
Cisplatin / administration & dosage
-
Cisplatin / adverse effects
-
Combined Modality Therapy
-
Gastrectomy*
-
Humans
-
Ileus / etiology*
-
Injections, Intraperitoneal / adverse effects*
-
Male
-
Middle Aged
-
Mitomycin / administration & dosage
-
Mitomycin / adverse effects
-
Neoplasm Invasiveness
-
Preoperative Care
-
Stomach Neoplasms / complications
-
Stomach Neoplasms / drug therapy*
-
Stomach Neoplasms / pathology
-
Stomach Neoplasms / surgery